1424 studies found for:    Open Studies | "Lung Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient
Condition: Lung Neoplasms
Interventions: Biological: MV mix vaccine;   Other: standard treatment
22 Unknown  BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer;   Small Cell Lung Cancer Recurrent
Intervention: Drug: BIBF 1120
23 Recruiting Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Progression of Non-small Cell Lung Cancer;   Non-small Cell Lung Cancer Recurrent
Interventions: Drug: Docetaxel;   Biological: HyperAcute®-Lung Immunotherapy;   Drug: Gemcitabine;   Drug: Pemetrexed
24 Recruiting Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)
Conditions: Non-small Cell Lung Cancer Stage I;   Non-small Cell Lung Cancer Stage II;   Non-small Cell Lung Cancer Stage IIIA
Intervention:
25 Recruiting Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)
Conditions: Non-small Cell Lung Cancer Stage IIIB/IV;   Non-small Cell Lung Cancer Metastatic;   Nonsquamous Nonsmall Cell Neoplasm of Lung
Interventions: Drug: metformin;   Behavioral: carbohydrate restricted diet
26 Not yet recruiting Virtual Intervention for Lung Cancer
Condition: Lung Neoplasms
Interventions: Behavioral: Virtual experience;   Behavioral: Videos
27 Recruiting Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)
Conditions: Lung Cancer;   Non Small Cell Lung Cancer.
Interventions: Drug: Patritumab;   Drug: erlotinib:;   Drug: Placebo
28 Recruiting TF2- Small Cell Lung Cancer Radio Immunotherapy
Conditions: Small Cell Lung Cancer;   CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Drug: Antibody TF2;   Radiation: IMP-288-Lutetium;   Radiation: IMP-288-Indium
29 Recruiting Specimen Banking From Patients With Lung Cancer
Condition: Lung Neoplasms
Intervention:
30 Recruiting Pegylated Irinotecan NKTR 102 in Treating Patients With Refractory Brain Metastasis From Non-small Cell Lung Cancer or Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Tumors Metastatic to Brain
Interventions: Drug: pegylated irinotecan NKTR 102;   Other: laboratory biomarker analysis
31 Recruiting A Study to Assess the Efficacy of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With FGFR1-driven Lung Cancer
Conditions: Squamous NSCLC;   Squamous Non-small Cell Lung Cancer;   Non-small Cell Lung Cancer;   Stage IV Lung Cancer;   Lung Cancer;   Metastatic Lung Cancer
Intervention: Drug: Lucitanib
32 Recruiting Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Conditions: Adenosquamous Lung Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
33 Recruiting A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
Conditions: Lung Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases
Interventions: Device: MIMIG System;   Drug: Indocyanine Green (ICG)
34 Recruiting DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
35 Recruiting Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer
Condition: Lung Neoplasms
Intervention:
36 Recruiting Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Dietary Supplement: soy isoflavones;   Drug: cisplatin;   Drug: etoposide;   Drug: pemetrexed disodium;   Radiation: radiation therapy
37 Recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: hypofractionated radiation therapy;   Other: laboratory biomarker analysis;   Radiation: image-guided radiation therapy;   Drug: carboplatin;   Drug: paclitaxel;   Radiation: stereotactic body radiation therapy
38 Unknown  Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
Condition: Lung Neoplasms
Interventions: Drug: gemcitabine, carboplatin;   Procedure: surgery
39 Recruiting A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Condition: Lung Neoplasms
Intervention: Radiation: Radiation Concurrent Chemotherapy
40 Recruiting Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
Condition: Lung Neoplasms
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years